Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $4.7 million.

  • Cellebrite DI's Change in Receivables fell 5465.26% to $4.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$15.8 million, marking a year-over-year decrease of 17073.25%. This contributed to the annual value of -$15.8 million for FY2025, which is 17073.25% down from last year.
  • Per Cellebrite DI's latest filing, its Change in Receivables stood at $4.7 million for Q4 2025, which was down 5465.26% from -$11.2 million recorded in Q3 2025.
  • Cellebrite DI's Change in Receivables' 5-year high stood at $15.3 million during Q1 2024, with a 5-year trough of -$24.4 million in Q3 2021.
  • Over the past 5 years, Cellebrite DI's median Change in Receivables value was $3.2 million (recorded in 2025), while the average stood at -$1.7 million.
  • Per our database at Business Quant, Cellebrite DI's Change in Receivables surged by 25526.17% in 2021 and then crashed by 20879.86% in 2024.
  • Cellebrite DI's Change in Receivables (Quarter) stood at $8.7 million in 2021, then grew by 29.37% to $11.2 million in 2022, then tumbled by 162.86% to -$7.1 million in 2023, then surged by 245.22% to $10.3 million in 2024, then plummeted by 54.65% to $4.7 million in 2025.
  • Its Change in Receivables was $4.7 million in Q4 2025, compared to -$11.2 million in Q3 2025 and -$10.9 million in Q2 2025.